 |
Virginia Administrative Code (Last Updated: January 10, 2017) |
 |
Title 12. Health |
|
Agency 30. Department of Medical Assistance Services |
|
Chapter 130. Amount, Duration, and Scope of Selected Services |
Section 380. Definitions
-
Part V. Drug Utilization Review in Nursing Facilities
The following words and terms, when used in this part, shall have the following meanings unless the context clearly indicates otherwise:
"DMAS" means the Department of Medical Assistance Services consistent with Chapter 10 (§ 32.1-323 et seq.) of Title 32.1 of the Code of Virginia.
"Drug utilization review" or "DUR" means a formal continuing program for assessing medical or drug use data against explicit standards and, as necessary, introducing remedial strategies.
"Drug Utilization Review Committee (DUR Committee)" means a committee composed of knowledgeable health care professionals who make recommendations for developing and modifying drug therapy review standards or criteria, participate in retrospective reviews, recommend remedial strategies, and evaluate the success of the interventions.
"Exceptional drug utilization pattern" means (i) a pattern of drug utilization within a nursing facility that differs substantially from predetermined standards established pursuant to 12VAC30-130-400 B; (ii) individual resident's drug use patterns that differ from the established standards; or (iii) individual resident's drug use patterns that exhibit a high risk for drug therapy induced illness.
"Retrospective utilization drug review" means the drug utilization review process that is conducted using historic or archived medical or drug use data.
"Targeted facility" means a nursing facility where residents' patterns of drug utilization demonstrate an exceptional drug utilization pattern as defined herein.
Historical Notes
Derived from VR460-05-3000 § 1, eff. September 25, 1991; amended, Volume 25, Issue 14, eff. April 15, 2009.